{
    "ticker": "EBS",
    "name": "Emergent BioSolutions Inc.",
    "description": "Emergent BioSolutions Inc. is a global life sciences company that specializes in developing, manufacturing, and delivering solutions for public health threats. Founded in 1998 and headquartered in Gaithersburg, Maryland, Emergent focuses on providing medical countermeasures for infectious diseases and biological threats, with a strong commitment to ensuring global health security. The company is recognized for its expertise in vaccine production, therapeutics, and other innovative products to address public health needs. Emergent's portfolio includes vaccines for anthrax and smallpox, as well as treatments for opioid overdose, among other critical healthcare solutions. The company partners with government agencies, healthcare organizations, and other stakeholders to respond effectively to emerging health crises and bioterrorism threats. With a mission to protect life and enhance health, Emergent is dedicated to advancing biotechnology and supporting preparedness initiatives across the globe.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Gaithersburg, Maryland, USA",
    "founded": "1998",
    "website": "https://www.emergentbiosolutions.com",
    "ceo": "Robert G. Kramer Jr.",
    "social_media": {
        "twitter": "https://twitter.com/emergentbiosol",
        "linkedin": "https://www.linkedin.com/company/emergent-biosolutions/"
    },
    "investor_relations": "https://investors.emergentbiosolutions.com",
    "key_executives": [
        {
            "name": "Robert G. Kramer Jr.",
            "position": "CEO"
        },
        {
            "name": "Daniel J. Abdun-Nabi",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Vaccines",
            "products": [
                "BioThrax",
                "ACAM2000"
            ]
        },
        {
            "category": "Therapeutics",
            "products": [
                "NARCAN",
                "EpiPen"
            ]
        }
    ],
    "seo": {
        "meta_title": "Emergent BioSolutions Inc. | Public Health Solutions",
        "meta_description": "Learn about Emergent BioSolutions Inc., a leader in biotechnology and pharmaceuticals focused on public health security. Explore their innovative products and mission.",
        "keywords": [
            "Emergent BioSolutions",
            "Biotechnology",
            "Vaccines",
            "Public Health",
            "BioThrax",
            "NARCAN"
        ]
    },
    "faq": [
        {
            "question": "What does Emergent BioSolutions specialize in?",
            "answer": "Emergent BioSolutions specializes in developing and manufacturing medical countermeasures for public health threats."
        },
        {
            "question": "Who is the CEO of Emergent BioSolutions?",
            "answer": "Robert G. Kramer Jr. is the CEO of Emergent BioSolutions Inc."
        },
        {
            "question": "Where is Emergent BioSolutions headquartered?",
            "answer": "Emergent BioSolutions is headquartered in Gaithersburg, Maryland, USA."
        },
        {
            "question": "What are some of Emergent's main products?",
            "answer": "Some of Emergent's main products include BioThrax, ACAM2000, and NARCAN."
        },
        {
            "question": "When was Emergent BioSolutions founded?",
            "answer": "Emergent BioSolutions was founded in 1998."
        }
    ],
    "competitors": [
        "NVAX",
        "VAXX",
        "BNTX",
        "MRNA"
    ],
    "related_stocks": [
        "JNJ",
        "PFE",
        "GSK",
        "AZN"
    ]
}